comprehensive -WSS

comprehensive

author：focus 2025-09-06 02:15:29 - browse：7886

Rising drug prices —Medicare coverage from STAT — Medicare on Friday released new details about how its new drug price negotiation program will work, just two months before it’s set to start. APStock

WASHINGTON — Medicare on Friday released new details about how its new drug price negotiation program will work, just two months before it’s set to start.

Medicare released an initial outline of how the program will work in March. Some parts, including the outline of how drugs would be selected for the negotiation process, were immediately final. The agency asked drug companies, patients, and other affected parties to weigh in on other parts about how the process would proceed, what factors would be considered, and how drugmakers would be held accountable.

Newsletters

Sign up for D.C. Diagnosis

An insider's guide to the politics and policies of health care

Please enter a valid email address. Privacy Policy

The negotiation process was created last August in Democrats’ drug pricing reform law, and Medicare is supposed to select the first 10 drugs that will be subject to negotiation by Sept. 1.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Health tech startups drop sharply from 2021 highs

WSS

Elizabeth Holmes banned from government health programs

The surgeon had a dilemma only a Nazi medical text could resolve

Address the ethical violations that led to 'Three Identical Strangers'

NIH director takes cautious approach to Biden drug pricing priority

Medicare drug price negotiation program allowed for now

Medicare drug price negotiation program allowed for now

focus

comprehensive

Sign up for D.C. Diagnosis

Wikipedia

Trump demands the U.S. pay no more for drugs than other countries … again

Kaiser Permanente unions announce official strike date

Jerome Adams on the need for new antivirals for Covid

Mindstrong's demise and the future of mental health care

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

What to make of Gilead’s Trodelvy troubles and Elevation Oncology’s rise

Psychedelics group wrestles with new pharma identity

What to make of Gilead’s Trodelvy troubles and Elevation Oncology’s rise

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Cigna to pay $172 million to settle Medicare Advantage fraud probe

explore

Senator probes 340B programs at Cleveland Clinic, Bon Secours

eGenesis tests gene

NIH director takes cautious approach to Biden drug pricing priority

Why doctors need education on FDA device approval process

Paxlovid should be available without a positive Covid test

What to make of Gilead’s Trodelvy troubles and Elevation Oncology’s rise

focus

knowledge

entertainment

explore